Antileishmanial activity of lapachol analogues

被引:72
作者
Lima, NMF
Correia, CS
Leon, LL
Machado, GMC
Madeira, MD
Santana, AEG
Goulart, MOF
机构
[1] Univ Fed Alagoas, Dept Quim, CCEN, BR-57072970 Maceio, AL, Brazil
[2] Fiocruz MS, Inst Oswaldo Cruz, Dept Immunol, BR-21045900 Rio De Janeiro, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2004年 / 99卷 / 07期
关键词
Leishmania amazonensis; Leishmania braziliensis; lapachol; isolapachol; antileishmanial activity; naphthoquinones;
D O I
10.1590/S0074-02762004000700017
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The antileishmanial activity of lapachol, isolapachol, and dihydrolapachol, along with soluble derivatives (potassium salt) and acetate was obtained. All the compounds were assayed against metacyclic promastigotes of two different species of Leishmania associated to tegumentar leishmaniasis. L. amazonensis and L. braziliensis. All compounds presented significant activity, being isolapachol acetate the most active against promastigotes, with IC50/24h = 1.6 +/- 0.0 mug/ml and 3.4 +/- 0.5 mug/ml for respectively, L. amazonensis and L. braziliensis. This compound was also assayed in vivo against L. amazonensis and showed to be active. Its toxicity in vitro was also established, and at concentration similar to the IC50, no toxicity was evidenced In all experiments, pentamidine isethionate was used as a reference drug. The present results reinforce the potential use of substituted hydroxyquinones and derivatives as promising antileishmanial drugs and suggest a continuing study within this class of compounds.
引用
收藏
页码:757 / 761
页数:5
相关论文
共 45 条
[1]  
Barr A, 1999, STAND MAG, V1, P44
[2]  
CantoCavalheiro MM, 1997, MICROBIOS, V90, P51
[3]   Characterisation of atovaquone resistance in Leishmania infantum promastigotes [J].
Cauchetier, E ;
Loiseau, PM ;
Lehman, J ;
Rivollet, D ;
Fleury, J ;
Astier, A ;
Deniau, M ;
Paul, M .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (08) :1043-1051
[4]   THE ACTIVITY OF HYDROXYNAPHTHOQUINONES AGAINST LEISHMANIA-DONOVANI [J].
CROFT, SL ;
HOGG, J ;
GUTTERIDGE, WE ;
HUDSON, AT ;
RANDALL, AW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (06) :827-832
[5]   Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes [J].
da Silva, EF ;
Canto-Cavalheiro, MM ;
Braz, VR ;
Cysne-Finkelstein, L ;
Leon, LL ;
Echevarria, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (12) :979-984
[6]   Leishmaniasis: new approaches to disease control [J].
Davies, CR ;
Kaye, P ;
Croft, SL ;
Sundar, S .
BRITISH MEDICAL JOURNAL, 2003, 326 (7385) :377-382
[7]  
De Moura KCG, 2001, J BRAZIL CHEM SOC, V12, P325
[8]  
Dinnen RD, 1997, ANTICANCER RES, V17, P1027
[9]  
dos Santos AF, 2000, INT J PARASITOL, V30, P1199, DOI 10.1016/S0020-7519(00)00114-4
[10]   Molluscicidal and trypanocidal activities of lapachol derivatives [J].
dos Santos, AF ;
Ferraz, PAL ;
de Abreu, FC ;
Chiari, E ;
Goulart, MOF ;
Sant'Ana, AEG .
PLANTA MEDICA, 2001, 67 (01) :92-93